Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug CuII(atsm)
The administration of MPTP selectively targets the dopaminergic system resulting in
Parkinsonism-like symptoms and is commonly used as a mice model of Parkinson's disease …
Parkinsonism-like symptoms and is commonly used as a mice model of Parkinson's disease …
The protective, rescue and therapeutic potential of multi-target iron-chelators for retinitis pigmentosa
B Lin, MBH Youdim - Free Radical Biology and Medicine, 2021 - Elsevier
Retinitis pigmentosa (RP) is a group of inherited diseases in which mutations result in the
initial loss of night vision, followed by complete blindness. There is currently no effective …
initial loss of night vision, followed by complete blindness. There is currently no effective …
Probing the multitargeting potential of n-hexane fraction of Gongronema latifolium leaves in neurodegeneration via in vitro, GC–MS and in silico studies
GA Gyebi, JC Ejoh, OM Ogunyemi, AM Ibrahim… - Future Journal of …, 2023 - Springer
Abstract Background Neurodegenerative disorders (NDDs) are associated with increased
activities of brain acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and …
activities of brain acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and …
Modulatory Effects of Alkaloid Extract from Gongronema latifolium (Utazi) and Lasianthera africana (Editan) on Activities of Enzymes Relevant to Neurodegeneration
Most alkaloids are produced by plants as a defense mechanism against herbivores. Since
alkaloids are known to possess pharmacological effects, this study sought to investigate the …
alkaloids are known to possess pharmacological effects, this study sought to investigate the …
Identification of potential inhibitors of cholinergic and β-secretase enzymes from phytochemicals derived from Gongronema latifolium Benth leaf: an integrated …
GA Gyebi, OM Ogunyemi, IM Ibrahim, OB Ogunro… - Molecular Diversity, 2023 - Springer
Neurodegenerative disorders (NDDs) are associated with increased activities of the brain
acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and β-secretase enzyme …
acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and β-secretase enzyme …
[HTML][HTML] The Molecular Mechanism of ferroptosis and Its Relationship with Parkinson's Disease
Y Su, Y Jiao, Q Wang, X Chen - Brain Research Bulletin, 2024 - Elsevier
Neurodegenerative diseases such as Parkinson's disease (PD) have complex pathogenetic
mechanisms. Genetic, age, and environmental factors are all related to PD. Due to the …
mechanisms. Genetic, age, and environmental factors are all related to PD. Due to the …
Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1G93A Transgenic ALS Mice
S Golko-Perez, T Amit, MBH Youdim… - Journal of Molecular …, 2016 - Springer
Accumulation of evidence has demonstrated high levels of iron in the central nervous
system of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients and in ALS …
system of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients and in ALS …
Piperazine derivatives as iron chelators: a potential application in neurobiology
S Abdelsayed, NT Ha Duong, C Bureau, PP Michel… - Biometals, 2015 - Springer
Polysubstituted piperazine derivatives, designed as new iron chelators, were synthesized
and fully characterized by nuclear magnetic resonance and mass spectroscopy. Their …
and fully characterized by nuclear magnetic resonance and mass spectroscopy. Their …
Diagnostics and treatments of iron-related CNS diseases
Iron has been proposed to be responsible for neuronal loss in several diseases of the
central nervous system, including Alzheimer's disease (AD), Parkinson's disease (PD) …
central nervous system, including Alzheimer's disease (AD), Parkinson's disease (PD) …
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases
I Cacciatore, L Marinelli, A Di Stefano, V Di Marco… - Neuropeptides, 2018 - Elsevier
Neurodegenerative diseases share a common pathogenetic mechanism involving
aggregation and deposition of misfolded proteins, oxidative stress, metal dyshomeostasis …
aggregation and deposition of misfolded proteins, oxidative stress, metal dyshomeostasis …